494 related articles for article (PubMed ID: 20168332)
1. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
Anastasia L; Pelissero G; Venerando B; Tettamanti G
Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
[TBL] [Abstract][Full Text] [Related]
2. Chemical strategies for stem cell biology and regenerative medicine.
Zhu S; Wei W; Ding S
Annu Rev Biomed Eng; 2011 Aug; 13():73-90. PubMed ID: 21513460
[TBL] [Abstract][Full Text] [Related]
3. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming.
Li W; Ding S
Trends Pharmacol Sci; 2010 Jan; 31(1):36-45. PubMed ID: 19896224
[TBL] [Abstract][Full Text] [Related]
4. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
5. Advances in cell lineage reprogramming.
Zhou J; Yue W; Pei X
Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
[TBL] [Abstract][Full Text] [Related]
6. [Induced pluripotent stem cells generated from reprogramming differentiated cells by defined factors].
Xia X; Chu J; Chen X
Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1121-7. PubMed ID: 18837383
[TBL] [Abstract][Full Text] [Related]
7. A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation.
Li Y; Geng YJ
Growth Horm IGF Res; 2010 Dec; 20(6):391-8. PubMed ID: 20956084
[TBL] [Abstract][Full Text] [Related]
8. How far are induced pluripotent stem cells from the clinic?
Li M; Chen M; Han W; Fu X
Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
[TBL] [Abstract][Full Text] [Related]
9. An introduction to induced pluripotent stem cells.
Hanley J; Rastegarlari G; Nathwani AC
Br J Haematol; 2010 Oct; 151(1):16-24. PubMed ID: 20666774
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming adult hematopoietic cells.
Kaneko S; Otsu M; Nakauchi H
Curr Opin Hematol; 2010 Jul; 17(4):271-5. PubMed ID: 20571391
[TBL] [Abstract][Full Text] [Related]
11. Prospects of induced pluripotent stem cell technology in regenerative medicine.
Zhang F; Citra F; Wang DA
Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
[TBL] [Abstract][Full Text] [Related]
12. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
Pan G; Wang T; Yao H; Pei D
Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
[TBL] [Abstract][Full Text] [Related]
13. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
Das AK; Pal R
J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cells: an emerging theranostics platform.
Nelson TJ; Terzic A
Clin Pharmacol Ther; 2011 May; 89(5):648-50. PubMed ID: 21512525
[TBL] [Abstract][Full Text] [Related]
15. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
[TBL] [Abstract][Full Text] [Related]
16. Modulation of embryonic stem cell fate and somatic cell reprogramming by small molecules.
Zhang XZ
Reprod Biomed Online; 2010 Jul; 21(1):26-36. PubMed ID: 20462797
[TBL] [Abstract][Full Text] [Related]
17. AID in reprogramming: quick and efficient: identification of a key enzyme called AID, and its activity in DNA demethylation, may help to overcome a pivotal epigenetic barrier in reprogramming somatic cells toward pluripotency.
Deng W
Bioessays; 2010 May; 32(5):385-7. PubMed ID: 20394066
[TBL] [Abstract][Full Text] [Related]
18. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
Romano G
Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
[TBL] [Abstract][Full Text] [Related]
19. Cell fate plug and play: direct reprogramming and induced pluripotency.
Chambers SM; Studer L
Cell; 2011 Jun; 145(6):827-30. PubMed ID: 21663788
[TBL] [Abstract][Full Text] [Related]
20. Concise review: non-cell autonomous reprogramming: a nucleic acid-free approach to induction of pluripotency.
Parameswaran S; Balasubramanian S; Rao MS; Ahmad I
Stem Cells; 2011 Jul; 29(7):1013-20. PubMed ID: 21544901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
